CEO SUMMARY: After routine testing and specimen volume declined last month, so too did the associated revenue. In response, clinical laboratories and anatomic pathology groups want to bolster their finances quickly or risk incurring more financial damage to already-fragile balance sheets. Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, and other stimulus plans from Congress, labs and pathology groups may …
Labs May Qualify for Relief Under New Federal Laws Read More »
